Journal
INFECTION AND IMMUNITY
Volume 85, Issue 4, Pages -Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/IAI.00841-16
Keywords
Plasmodium falciparum; antigenic variation; gene expression; malaria; PfEMP1
Categories
Funding
- Augustinus Fonden
- Lundbeckfonden
- Axel Muusfeldts Fond
- Danish International Development Agency (DANIDA)
- Danish Council for Independent Research [T1333-00220 1331-00089B, DFF-400400624B]
- Grosserer L. F. Foghts Fond
- Lundbeck Foundation [R77-2010-7185, R140-2013-13448] Funding Source: researchfish
Ask authors/readers for more resources
By attaching infected erythrocytes to the vascular lining, Plasmodium falciparum parasites leave blood circulation and avoid splenic clearance. This sequestration is central to pathogenesis. Severe malaria is associated with parasites expressing an antigenically distinct P. falciparum erythrocyte membrane protein 1 (PfEMP1) subset mediating binding to endothelial receptors. Previous studies indicate that PfEMP1 adhesins with so-called CIDR alpha 1 domains capable of binding endothelial protein C receptor (EPCR) constitute the PfEMP1 subset associated with severe pediatric malaria. To analyze the relative importance of different subtypes of CIDR alpha 1 domains, we compared Pfemp1 transcript levels in children with severe malaria (including 9 fatal and 114 surviving cases), children hospitalized with uncomplicated malaria (n = 42), children with mild malaria not requiring hospitalization (n = 10), and children with parasitemia and no ongoing fever (n = 12). High levels of transcripts encoding EPCR-binding PfEMP1 were found in patients with symptomatic infections, and the abundance of these transcripts increased with disease severity. The compositions of CIDR alpha 1 subtype transcripts varied markedly between patients, and none of the subtypes were dominant. Transcript-level analyses targeting other domain types indicated that subtypes of DBL beta or DBL zeta domains might mediate binding phenomena that, in conjunction with EPCR binding, could contribute to pathogenesis. These observations strengthen the rationale for targeting the PfEMP1-EPCR interaction by vaccines and adjunctive therapies. Interventions should target EPCR binding of all CIDR alpha 1 subtypes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available